Pottier, C., Montero-Ruiz, L., Jehay, R., Wery, C., Baiwir, D., Mazzucchelli, G., Bekisz, S., Thissen, R., Josse, C., Rorive, A., Gofflot, S., Dahmani, A., Morisset, L., Collignon, J., Delvenne, P., Marangoni, E., Noël, A., Jerusalem, G., & Sounni, N. E. (2025). Targeting ferroptosis resistance resensitizes metastatic HR+HER2- breast cancer cells to palbociclib-hormone therapy. Cancer Communications. doi:10.1002/cac2.12646 |
Luis, G.* , Godfroid, A.* , Nishiumi, S., Cimino, J., Blacher, S., Maquoi, E., Wery, C., Collignon, A., Longuespée, R., MONTERORUIZ, L., Dassoul, I., Maloujahmoum, N., Pottier, C., Mazzucchelli, G., De Pauw, E., Bellahcene, A., Yoshida, M., Noël, A., & Sounni, N. E. (2021). Tumor resistance to ferroptosis driven by Stearoyl-CoA Desaturase-1 (SCD1) in cancer cells and Fatty Acid Biding Protein-4 (FABP4) in tumor microenvironment promote tumor recurrence. Redox Biology, 43, 102006. doi:10.1016/j.redox.2021.102006 * Ces auteurs ont contribué de façon équivalente à la publication. |